UB Paderborn / Katalog / Suche / in CDI

Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial

Lancet neurology, 2016-04, Vol.15 (4), p.365-372

2016

Link zum Volltext

Verfügbarkeit prüfen

Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies

The Annals of pharmacotherapy, 2011-11, Vol.45 (11), p.1406

2011

Link zum Volltext

Verfügbarkeit prüfen

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force

Epilepsia open, 2021-03, Vol.6 (1), p.45-48

2021

Link zum Volltext

Verfügbarkeit prüfen

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force

Epilepsia open, 2022-06, Vol.7 (2), p.260-270

2022

Link zum Volltext

Verfügbarkeit prüfen

Unity in Diversity and the Standardisation of Clinical Pharmacy Services: Proceedings of the 17th Asian Conference on Clinical Pharmacy (ACCP 2017), July 28-30, 2017, Yogyakarta, Indonesia

1, 2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of limited transportation on medication adherence in patients with epilepsy

Journal of the American Pharmacists Association, 2010-11, Vol.50 (6), p.698-703

2010

Link zum Volltext

Verfügbarkeit prüfen

Management of hallucinations and psychosis in Parkinson's disease

The American journal of geriatric pharmacotherapy, 2010-08, Vol.8 (4), p.316

2010

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial

JAMA neurology, 2017-08, Vol.74 (8), p.919

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee

Epilepsy currents, 2020-09, Vol.20 (5), p.245-264

2020

Link zum Volltext

Verfügbarkeit prüfen

Coffee and cigarette smoking interactions with lamotrigine

Epilepsy & behavior, 2021-03, Vol.116, p.107741, Article 107741

2021

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications

Epileptic disorders, 2022-10, Vol.24 (5), p.751-764

2022

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal Dosing of Benzodiazepines and Levetiracetam in a Cohort of Status Epilepticus Patients and Outcomes Associated with Inadequate Dosing

Journal of pharmacy practice, 2023-10, Vol.36 (5), p.1068-1071

2023

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol: Promise and Pitfalls: Cannabidiol: Promise and Pitfalls

Epilepsy Currents, 2014-09, Vol.14 (5), p.250-252

2014

Link zum Volltext

Verfügbarkeit prüfen

Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults

The Annals of pharmacotherapy, 2012-10, Vol.46 (10), p.1358

2012

Link zum Volltext

Verfügbarkeit prüfen

American College of Clinical Pharmacy's Vision of the Future: Postgraduate Pharmacy Residency Training as a Prerequisite for Direct Patient Care Practice

Pharmacotherapy, 2006-05, Vol.26 (5), p.722-733

2006

Link zum Volltext

Verfügbarkeit prüfen

FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force

Epilepsy currents, 2021-05, Vol.21 (3), p.150-153

2021

Link zum Volltext

Verfügbarkeit prüfen

American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019

Epilepsy currents, 2019-11, Vol.19 (6), p.361-368

2019

Link zum Volltext

Verfügbarkeit prüfen

The Essential Research Curriculum for Doctor of Pharmacy Degree Programs

Pharmacotherapy, 2010-09, Vol.30 (9), p.966-966

2010

Link zum Volltext

Verfügbarkeit prüfen

Generic substitution of antiepileptic drugs: a telephone survey

The Annals of pharmacotherapy, 2010-05, Vol.44 (5), p.938

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacy and generic substitution of antiepileptic drugs: missing in action?

The Annals of pharmacotherapy, 2007-06, Vol.41 (6), p.1065

Welty, Timothy E

2007

Link zum Volltext

Verfügbarkeit prüfen

Neurology and neurosurgery clinical pharmacy practice: ignorance, phobia, or progress?

The Annals of pharmacotherapy, 2006-12, Vol.40 (12), p.2235

Welty, Timothy E

2006

Link zum Volltext

Verfügbarkeit prüfen

Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management

Paediatric drugs, 2006, Vol.8 (5), p.303-310

Welty, Timothy E

2006

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care testing: an introduction

The Annals of pharmacotherapy, 2004-01, Vol.38 (1), p.119

2004

Link zum Volltext

Verfügbarkeit prüfen

Be Sure to Read the Fine Print: The Agency for Healthcare Research and Quality Comparative Effectiveness Report on Antiepileptic Drugs

Epilepsy currents, 2012-05, Vol.12 (3), p.84-86

2012

Link zum Volltext

Verfügbarkeit prüfen

Levetiracetam: a different approach to the pharmacotherapy of epilepsy

The Annals of pharmacotherapy, 2002-02, Vol.36 (2), p.296

2002

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial

Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force

Unity in Diversity and the Standardisation of Clinical Pharmacy Services: Proceedings of the 17th Asian Conference on Clinical Pharmacy (ACCP 2017), July 28-30, 2017, Yogyakarta, Indonesia

Effect of limited transportation on medication adherence in patients with epilepsy

Management of hallucinations and psychosis in Parkinson's disease

Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial

Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee

Coffee and cigarette smoking interactions with lamotrigine

Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications

Suboptimal Dosing of Benzodiazepines and Levetiracetam in a Cohort of Status Epilepticus Patients and Outcomes Associated with Inadequate Dosing

Cannabidiol: Promise and Pitfalls: Cannabidiol: Promise and Pitfalls

Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults

American College of Clinical Pharmacy's Vision of the Future: Postgraduate Pharmacy Residency Training as a Prerequisite for Direct Patient Care Practice

FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force

The Essential Research Curriculum for Doctor of Pharmacy Degree Programs

Generic substitution of antiepileptic drugs: a telephone survey

Pharmacy and generic substitution of antiepileptic drugs: missing in action?

Neurology and neurosurgery clinical pharmacy practice: ignorance, phobia, or progress?

Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management

Point-of-care testing: an introduction

Be Sure to Read the Fine Print: The Agency for Healthcare Research and Quality Comparative Effectiveness Report on Antiepileptic Drugs

Levetiracetam: a different approach to the pharmacotherapy of epilepsy

Suchergebnisse filtern